What's new

EMEA-003395-PIP02-23

EMEA-003395-PIP02-23

Jun 10, 2025 - 15:05
 0
EMEA-003395-PIP02-23
EMEA-003395-PIP02-23
Read More

Tags:

Previous Article

QRD Appendix V - Adverse-drug-reaction reporting details

Next Article

EMEA-003454-PIP01-23

Related Posts

Referral: Mysimba, naltrexone,bupropion Article 20 procedures European Commission final decision, 27/03/2025, 22/05/2025, 26/05/2025

Referral: Mysimba, naltrexone,bupropion Article 20 proc...

May 26, 2025  0

Orphan designation: Ganaxolone Treatment of CDKL5 deficiency disorder, 13/11/2019 Positive

Orphan designation: Ganaxolone Treatment of CDKL5 defic...

Jun 5, 2025  0

IVF Media G5 - Procedural steps and scientific informat...

May 12, 2025  0